Evaluation of Microsomal Incubation Conditions on CYP3A4-Mediated Metabolism of Cyclosporine A by a Statistical Experimental Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|7|3|265-271

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.7, Iss.3, 2006-04, pp. : 265-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs

By Patel Jignesh   Mitra Ashim K  

Pharmacogenomics, Vol. 2, Iss. 4, 2001-11 ,pp. : 401-415

Future Medicine

Access to resources Recommend Favorite

Enantioselective transport and CYP3A4-mediated metabolism of R/S-verapamil in Caco-2 cell monolayers

By Engman H.   Tannergren C.   Artursson P.   Lennernas H.  

European Journal of Pharmaceutical Sciences, Vol. 19, Iss. 1, 2003-05 ,pp. : 57-65

Elsevier

Access to resources Recommend Favorite

Inhibition of CYP3A4 and CYP3A5 catalyzed metabolism of alprazolam and quinine by ketoconazole as racemate and four different enantiomers

By Allqvist Annika   Miura Jun   Bertilsson Leif   Mirghani Rajaa  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 173-179

Springer Publishing Company

Access to resources Recommend Favorite

CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy

By  

Current Drug Metabolism, Vol. 15, Iss. 8, 2014-10 ,pp. : 808-817

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism

By de Jonge Hylke   de Loor Henriette   Verbeke Krisitin   Vanrenterghem Yves   Kuypers Dirk RJ  

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1467-1480

Future Medicine

Access to resources Recommend Favorite